UniProt ID | PTPRS_HUMAN | |
---|---|---|
UniProt AC | Q13332 | |
Protein Name | Receptor-type tyrosine-protein phosphatase S | |
Gene Name | PTPRS | |
Organism | Homo sapiens (Human). | |
Sequence Length | 1948 | |
Subcellular Localization |
Cell membrane Single-pass type I membrane protein . Cell projection, axon . Perikaryon . Cytoplasmic vesicle, secretory vesicle, synaptic vesicle membrane . Cell junction, synapse, synaptosome . Cell junction, synapse, postsynaptic cell membrane, postsy |
|
Protein Description | Cell surface receptor that binds to glycosaminoglycans, including chondroitin sulfate proteoglycans and heparan sulfate proteoglycan. [PubMed: 21454754 Binding to chondroitin sulfate and heparan sulfate proteoglycans has opposite effects on PTPRS oligomerization and regulation of neurite outgrowth. Contributes to the inhibition of neurite and axonal outgrowth by chondroitin sulfate proteoglycans, also after nerve transection. Plays a role in stimulating neurite outgrowth in response to the heparan sulfate proteoglycan GPC2. Required for normal brain development, especially for normal development of the pituitary gland and the olfactory bulb. Functions as tyrosine phosphatase] | |
Protein Sequence | MAPTWGPGMVSVVGPMGLLVVLLVGGCAAEEPPRFIKEPKDQIGVSGGVASFVCQATGDPKPRVTWNKKGKKVNSQRFETIEFDESAGAVLRIQPLRTPRDENVYECVAQNSVGEITVHAKLTVLREDQLPSGFPNIDMGPQLKVVERTRTATMLCAASGNPDPEITWFKDFLPVDPSASNGRIKQLRSETFESTPIRGALQIESSEETDQGKYECVATNSAGVRYSSPANLYVRELREVRRVAPRFSILPMSHEIMPGGNVNITCVAVGSPMPYVKWMQGAEDLTPEDDMPVGRNVLELTDVKDSANYTCVAMSSLGVIEAVAQITVKSLPKAPGTPMVTENTATSITITWDSGNPDPVSYYVIEYKSKSQDGPYQIKEDITTTRYSIGGLSPNSEYEIWVSAVNSIGQGPPSESVVTRTGEQAPASAPRNVQARMLSATTMIVQWEEPVEPNGLIRGYRVYYTMEPEHPVGNWQKHNVDDSLLTTVGSLLEDETYTVRVLAFTSVGDGPLSDPIQVKTQQGVPGQPMNLRAEARSETSITLSWSPPRQESIIKYELLFREGDHGREVGRTFDPTTSYVVEDLKPNTEYAFRLAARSPQGLGAFTPVVRQRTLQSKPSAPPQDVKCVSVRSTAILVSWRPPPPETHNGALVGYSVRYRPLGSEDPEPKEVNGIPPTTTQILLEALEKWTQYRITTVAHTEVGPGPESSPVVVRTDEDVPSAPPRKVEAEALNATAIRVLWRSPAPGRQHGQIRGYQVHYVRMEGAEARGPPRIKDVMLADAQWETDDTAEYEMVITNLQPETAYSITVAAYTMKGDGARSKPKVVVTKGAVLGRPTLSVQQTPEGSLLARWEPPAGTAEDQVLGYRLQFGREDSTPLATLEFPPSEDRYTASGVHKGATYVFRLAARSRGGLGEEAAEVLSIPEDTPRGHPQILEAAGNASAGTVLLRWLPPVPAERNGAIVKYTVAVREAGALGPARETELPAAAEPGAENALTLQGLKPDTAYDLQVRAHTRRGPGPFSPPVRYRTFLRDQVSPKNFKVKMIMKTSVLLSWEFPDNYNSPTPYKIQYNGLTLDVDGRTTKKLITHLKPHTFYNFVLTNRGSSLGGLQQTVTAWTAFNLLNGKPSVAPKPDADGFIMVYLPDGQSPVPVQSYFIVMVPLRKSRGGQFLTPLGSPEDMDLEELIQDISRLQRRSLRHSRQLEVPRPYIAARFSVLPPTFHPGDQKQYGGFDNRGLEPGHRYVLFVLAVLQKSEPTFAASPFSDPFQLDNPDPQPIVDGEEGLIWVIGPVLAVVFIICIVIAILLYKNKPDSKRKDSEPRTKCLLNNADLAPHHPKDPVEMRRINFQTPDSGLRSPLREPGFHFESMLSHPPIPIADMAEHTERLKANDSLKLSQEYESIDPGQQFTWEHSNLEVNKPKNRYANVIAYDHSRVILQPIEGIMGSDYINANYVDGYRCQNAYIATQGPLPETFGDFWRMVWEQRSATIVMMTRLEEKSRIKCDQYWPNRGTETYGFIQVTLLDTIELATFCVRTFSLHKNGSSEKREVRQFQFTAWPDHGVPEYPTPFLAFLRRVKTCNPPDAGPIVVHCSAGVGRTGCFIVIDAMLERIKPEKTVDVYGHVTLMRSQRNYMVQTEDQYSFIHEALLEAVGCGNTEVPARSLYAYIQKLAQVEPGEHVTGMELEFKRLANSKAHTSRFISANLPCNKFKNRLVNIMPYESTRVCLQPIRGVEGSDYINASFIDGYRQQKAYIATQGPLAETTEDFWRMLWENNSTIVVMLTKLREMGREKCHQYWPAERSARYQYFVVDPMAEYNMPQYILREFKVTDARDGQSRTVRQFQFTDWPEQGVPKSGEGFIDFIGQVHKTKEQFGQDGPISVHCSAGVGRTGVFITLSIVLERMRYEGVVDIFQTVKMLRTQRPAMVQTEDEYQFCYQAALEYLGSFDHYAT | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
214 | Phosphorylation | EETDQGKYECVATNS CCCCCCEEEEEEECC | 22.76 | 30576142 | |
219 | Phosphorylation | GKYECVATNSAGVRY CEEEEEEECCCCCCC | 14.87 | 30576142 | |
221 | Phosphorylation | YECVATNSAGVRYSS EEEEEECCCCCCCCC | 23.26 | 30576142 | |
263 | N-linked_Glycosylation | IMPGGNVNITCVAVG CCCCCCEEEEEEECC | 28.05 | 25385546 | |
308 | N-linked_Glycosylation | TDVKDSANYTCVAMS CCCCCCCCCEEEEEC | 36.28 | 25385546 | |
383 (in isoform 6) | Phosphorylation | - | 34.14 | - | |
383 (in isoform 7) | Phosphorylation | - | 34.14 | - | |
387 | Phosphorylation | EDITTTRYSIGGLSP ECEECCEEEECCCCC | 11.53 | 20068231 | |
388 | Phosphorylation | DITTTRYSIGGLSPN CEECCEEEECCCCCC | 16.09 | 20068231 | |
393 | Phosphorylation | RYSIGGLSPNSEYEI EEEECCCCCCCCEEE | 25.88 | 20068231 | |
396 | Phosphorylation | IGGLSPNSEYEIWVS ECCCCCCCCEEEEEE | 44.96 | 20068231 | |
398 | Phosphorylation | GLSPNSEYEIWVSAV CCCCCCCEEEEEEEH | 16.73 | 20068231 | |
403 | Phosphorylation | SEYEIWVSAVNSIGQ CCEEEEEEEHHHCCC | 16.11 | 20068231 | |
407 | Phosphorylation | IWVSAVNSIGQGPPS EEEEEHHHCCCCCCC | 22.84 | 20068231 | |
414 | Phosphorylation | SIGQGPPSESVVTRT HCCCCCCCCCEEECC | 45.71 | 20068231 | |
416 | Phosphorylation | GQGPPSESVVTRTGE CCCCCCCCEEECCCC | 26.65 | 20068231 | |
419 | Phosphorylation | PPSESVVTRTGEQAP CCCCCEEECCCCCCC | 21.98 | 20068231 | |
483 | Phosphorylation | QKHNVDDSLLTTVGS HHCCCCHHHHHHHHH | 22.33 | 26074081 | |
486 | Phosphorylation | NVDDSLLTTVGSLLE CCCHHHHHHHHHHHC | 25.40 | 26074081 | |
487 | Phosphorylation | VDDSLLTTVGSLLED CCHHHHHHHHHHHCC | 23.88 | 26074081 | |
490 | Phosphorylation | SLLTTVGSLLEDETY HHHHHHHHHHCCCCE | 25.99 | 26074081 | |
537 | Phosphorylation | NLRAEARSETSITLS CCCEEECCCCEEEEE | 52.88 | 23403867 | |
544 | Phosphorylation | SETSITLSWSPPRQE CCCEEEEECCCCCCH | 19.50 | 23403867 | |
546 | Phosphorylation | TSITLSWSPPRQESI CEEEEECCCCCCHHE | 22.96 | 23403867 | |
552 | Phosphorylation | WSPPRQESIIKYELL CCCCCCHHEEEEEEE | 22.67 | 24719451 | |
556 | Phosphorylation | RQESIIKYELLFREG CCHHEEEEEEEEECC | 11.03 | 21406692 | |
610 | Dimethylation | GAFTPVVRQRTLQSK CCCCHHHHHHHCCCC | 22.09 | - | |
610 | Methylation | GAFTPVVRQRTLQSK CCCCHHHHHHHCCCC | 22.09 | 30762979 | |
696 | Phosphorylation | WTQYRITTVAHTEVG HHCCEEEEEEECCCC | 17.21 | 19690332 | |
700 | O-linked_Glycosylation | RITTVAHTEVGPGPE EEEEEEECCCCCCCC | 23.72 | OGP | |
700 | Phosphorylation | RITTVAHTEVGPGPE EEEEEEECCCCCCCC | 23.72 | 19690332 | |
708 | Phosphorylation | EVGPGPESSPVVVRT CCCCCCCCCCEEEEC | 42.97 | 19690332 | |
709 | Phosphorylation | VGPGPESSPVVVRTD CCCCCCCCCEEEECC | 21.76 | 19690332 | |
720 (in isoform 6) | N-linked_Glycosylation | - | 36.78 | - | |
733 | N-linked_Glycosylation | KVEAEALNATAIRVL CHHHHHHCCCEEHHH | 42.15 | 19159218 | |
733 | N-linked_Glycosylation | KVEAEALNATAIRVL CHHHHHHCCCEEHHH | 42.15 | 16335952 | |
756 | Phosphorylation | QHGQIRGYQVHYVRM CCCEECCEEEEEEEE | 9.49 | 24043423 | |
760 | Phosphorylation | IRGYQVHYVRMEGAE ECCEEEEEEEECCHH | 7.30 | 24043423 | |
803 | Phosphorylation | ITNLQPETAYSITVA EECCCCCCCEEEEEE | 37.26 | - | |
812 | Phosphorylation | YSITVAAYTMKGDGA EEEEEEEEEECCCCC | 9.53 | - | |
813 | Phosphorylation | SITVAAYTMKGDGAR EEEEEEEEECCCCCC | 14.00 | - | |
837 | O-linked_Glycosylation | GAVLGRPTLSVQQTP CCCCCCCEEEEEECC | 30.24 | OGP | |
843 | O-linked_Glycosylation | PTLSVQQTPEGSLLA CEEEEEECCCCCEEE | 13.25 | OGP | |
843 | Phosphorylation | PTLSVQQTPEGSLLA CEEEEEECCCCCEEE | 13.25 | 25159151 | |
858 | Phosphorylation | RWEPPAGTAEDQVLG EECCCCCCHHHHCCE | 29.04 | 26074081 | |
866 | Phosphorylation | AEDQVLGYRLQFGRE HHHHCCEEEEECCCC | 12.18 | 26074081 | |
875 | Phosphorylation | LQFGREDSTPLATLE EECCCCCCCCCEEEE | 27.46 | 26074081 | |
876 | Phosphorylation | QFGREDSTPLATLEF ECCCCCCCCCEEEEC | 34.34 | 26074081 | |
880 | Phosphorylation | EDSTPLATLEFPPSE CCCCCCEEEECCCCC | 34.21 | 26074081 | |
891 | Phosphorylation | PPSEDRYTASGVHKG CCCCCCCCCCCCCCC | 18.42 | - | |
893 | Phosphorylation | SEDRYTASGVHKGAT CCCCCCCCCCCCCCC | 33.28 | - | |
900 | Phosphorylation | SGVHKGATYVFRLAA CCCCCCCCHHHHHHH | 28.96 | 24144214 | |
901 | Phosphorylation | GVHKGATYVFRLAAR CCCCCCCHHHHHHHH | 9.32 | 24144214 | |
917 (in isoform 7) | Phosphorylation | - | 12.48 | 27251275 | |
922 (in isoform 7) | Phosphorylation | - | 41.07 | 27251275 | |
940 | N-linked_Glycosylation | QILEAAGNASAGTVL HHHHHHCCCCCCEEE | 26.45 | UniProtKB CARBOHYD | |
965 | Phosphorylation | RNGAIVKYTVAVREA CCCEEEEEEEEEHHC | 8.78 | 22210691 | |
966 | Phosphorylation | NGAIVKYTVAVREAG CCEEEEEEEEEHHCC | 9.03 | 22210691 | |
996 | Phosphorylation | PGAENALTLQGLKPD CCCCCCEEECCCCCC | 18.02 | 22210691 | |
1022 | Phosphorylation | RRGPGPFSPPVRYRT CCCCCCCCCCCCHHH | 31.28 | 28674419 | |
1027 | Phosphorylation | PFSPPVRYRTFLRDQ CCCCCCCHHHHCCCC | 17.78 | 24719451 | |
1036 | Phosphorylation | TFLRDQVSPKNFKVK HHCCCCCCCCCCEEE | 25.23 | 24719451 | |
1062 | Phosphorylation | EFPDNYNSPTPYKIQ ECCCCCCCCCCEEEE | 21.57 | 23312004 | |
1219 | Phosphorylation | RFSVLPPTFHPGDQK EEEECCCCCCCCCCC | 32.41 | 24719451 | |
1228 | Phosphorylation | HPGDQKQYGGFDNRG CCCCCCCCCCCCCCC | 26.67 | 24719451 | |
1317 | Phosphorylation | PDSKRKDSEPRTKCL CCCCCCCCCCCHHHH | 53.16 | 26699800 | |
1322 | Ubiquitination | KDSEPRTKCLLNNAD CCCCCCHHHHHCCCC | 24.94 | - | |
1326 (in isoform 6) | Phosphorylation | - | 28.79 | 27251275 | |
1331 (in isoform 6) | Phosphorylation | - | 11.26 | 27251275 | |
1344 (in isoform 3) | Phosphorylation | - | 4.23 | 27251275 | |
1349 (in isoform 3) | Phosphorylation | - | 24.00 | 27251275 | |
1366 | Phosphorylation | EPGFHFESMLSHPPI CCCCCHHHHHCCCCC | 24.87 | 27251275 | |
1382 | Phosphorylation | IADMAEHTERLKAND HHHHHHHHHHHHHCC | 17.82 | 27251275 | |
1386 | Ubiquitination | AEHTERLKANDSLKL HHHHHHHHHCCCCHH | 51.90 | - | |
1392 | Ubiquitination | LKANDSLKLSQEYES HHHCCCCHHHHHHHC | 50.47 | - | |
1397 | Phosphorylation | SLKLSQEYESIDPGQ CCHHHHHHHCCCCCC | 13.82 | - | |
1417 | Ubiquitination | HSNLEVNKPKNRYAN CCCCEECCCCCCEEE | 63.65 | 21906983 | |
1422 | Phosphorylation | VNKPKNRYANVIAYD ECCCCCCEEEEEEEC | 16.36 | 21945579 | |
1428 | Phosphorylation | RYANVIAYDHSRVIL CEEEEEEECCCCEEE | 11.76 | 28796482 | |
1431 | Phosphorylation | NVIAYDHSRVILQPI EEEEECCCCEEEEEC | 25.91 | 28796482 | |
1484 | Phosphorylation | RMVWEQRSATIVMMT HHHHHHHCCEEEEEE | 29.47 | - | |
1486 | Phosphorylation | VWEQRSATIVMMTRL HHHHHCCEEEEEECC | 18.49 | - | |
1492 | Dimethylation | ATIVMMTRLEEKSRI CEEEEEECCHHHHCC | 23.39 | - | |
1492 | Methylation | ATIVMMTRLEEKSRI CEEEEEECCHHHHCC | 23.39 | 24377377 | |
1662 | Phosphorylation | EVPARSLYAYIQKLA CCCHHHHHHHHHHHC | 9.90 | 28796482 | |
1685 | Ubiquitination | TGMELEFKRLANSKA CCCEEEHHHHHCCCC | 36.81 | - | |
1694 | Phosphorylation | LANSKAHTSRFISAN HHCCCCCHHHHHHCC | 26.85 | - | |
1695 | Phosphorylation | ANSKAHTSRFISANL HCCCCCHHHHHHCCC | 18.48 | - | |
1706 | Ubiquitination | SANLPCNKFKNRLVN HCCCCCHHHCCCCEE | 65.51 | - | |
1717 | Phosphorylation | RLVNIMPYESTRVCL CCEEECCCCCCEEEE | 12.72 | - | |
1720 | Phosphorylation | NIMPYESTRVCLQPI EECCCCCCEEEEEEC | 18.38 | - | |
1733 | Phosphorylation | PIRGVEGSDYINASF ECCCCCCCCCCCHHH | 17.46 | 21945579 | |
1735 | Phosphorylation | RGVEGSDYINASFID CCCCCCCCCCHHHCC | 9.58 | 21945579 | |
1793 | Phosphorylation | GREKCHQYWPAERSA CHHHHHHHCCCCHHC | 6.95 | - | |
1818 | Phosphorylation | AEYNMPQYILREFKV HHCCCCHHHHEEEEE | 8.96 | - | |
1824 | Ubiquitination | QYILREFKVTDARDG HHHHEEEEEECCCCC | 39.20 | - | |
1826 | Phosphorylation | ILREFKVTDARDGQS HHEEEEEECCCCCCC | 25.24 | - | |
1833 | Phosphorylation | TDARDGQSRTVRQFQ ECCCCCCCEEEEEEE | 35.13 | - | |
1835 | Phosphorylation | ARDGQSRTVRQFQFT CCCCCCEEEEEEEEC | 25.86 | - | |
1851 | Ubiquitination | WPEQGVPKSGEGFID CCCCCCCCCCCCHHH | 69.55 | - | |
1902 | Phosphorylation | IVLERMRYEGVVDIF HHHHHHCCCCHHHHH | 14.00 | 27762562 | |
1911 | Phosphorylation | GVVDIFQTVKMLRTQ CHHHHHHHHHHHHCC | 16.02 | 27762562 | |
1939 | Phosphorylation | CYQAALEYLGSFDHY HHHHHHHHHCCCCCC | 19.74 | - | |
1942 | Phosphorylation | AALEYLGSFDHYAT- HHHHHHCCCCCCCC- | 25.55 | 28176443 | |
1946 | Phosphorylation | YLGSFDHYAT----- HHCCCCCCCC----- | 17.49 | 28796482 | |
1948 | Phosphorylation | GSFDHYAT------- CCCCCCCC------- | 31.79 | 28796482 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of PTPRS_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of PTPRS_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PTPRS_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
CHD3_HUMAN | CHD3 | physical | 16169070 | |
FEZ1_HUMAN | FEZ1 | physical | 16169070 | |
PROF2_HUMAN | PFN2 | physical | 16169070 | |
UT14A_HUMAN | UTP14A | physical | 16169070 | |
SETB1_HUMAN | SETDB1 | physical | 16169070 | |
KAT5_HUMAN | KAT5 | physical | 16169070 | |
TBB2A_HUMAN | TUBB2A | physical | 16169070 | |
UBR1_HUMAN | UBR1 | physical | 16169070 | |
PTN_HUMAN | PTN | physical | 16169070 | |
EF1G_HUMAN | EEF1G | physical | 16169070 | |
CE126_HUMAN | KIAA1377 | physical | 16169070 | |
U119A_HUMAN | UNC119 | physical | 16169070 | |
LIPA1_HUMAN | PPFIA1 | physical | 8524829 | |
PTPRD_HUMAN | PTPRD | physical | 9566880 | |
LIPA1_HUMAN | PPFIA1 | physical | 9624153 | |
LIPA2_HUMAN | PPFIA2 | physical | 9624153 | |
LIPA3_HUMAN | PPFIA3 | physical | 9624153 | |
TRIO_HUMAN | TRIO | physical | 27880917 | |
LIPA1_HUMAN | PPFIA1 | physical | 27880917 | |
PTPRF_HUMAN | PTPRF | physical | 27880917 | |
CSKI2_HUMAN | CASKIN2 | physical | 27880917 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
N-linked Glycosylation | |
Reference | PubMed |
"Mass-spectrometric identification and relative quantification of N-linked cell surface glycoproteins."; Wollscheid B., Bausch-Fluck D., Henderson C., O'Brien R., Bibel M.,Schiess R., Aebersold R., Watts J.D.; Nat. Biotechnol. 27:378-386(2009). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-733, AND MASSSPECTROMETRY. | |
"Glycoproteomics analysis of human liver tissue by combination ofmultiple enzyme digestion and hydrazide chemistry."; Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.; J. Proteome Res. 8:651-661(2009). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-733, AND MASSSPECTROMETRY. | |
"Human plasma N-glycoproteome analysis by immunoaffinity subtraction,hydrazide chemistry, and mass spectrometry."; Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E.,Moore R.J., Smith R.D.; J. Proteome Res. 4:2070-2080(2005). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-733, AND MASSSPECTROMETRY. |